Fumaric acid esters in the management of psoriasis

References

• MrowietzUAsadullahKDimethylfumarate for psoriasis: more than a dietary curiosityTrends Mol Med2005111434815649822
   PubMed Web of Science ®Google Scholar
• RaimundoNBaysalBEShadelGSRevisiting the TCA cycle: signaling to tumor formationTrends Mol Med2011171164164921764377
   PubMed Web of Science ®Google Scholar
• SchweckendiekW[Treatment of psoriasis vulgaris] Heilung von Psoriasis vulgarisMed Monatsschr195913210310413643669
   PubMedGoogle Scholar
• SchweckendiekWBehandlung von psoriasis mit lipoidloslichen fumarsaureverbindungenMedizin Heute196615219220
   Google Scholar
• SchaferGFumarsaure lindert die schuppenflechteSelecta19841512601261
   Google Scholar
• van DijkE[Fumaric acid in the treatment of patients with psoriasis] Fumaarzuur voor de behandeling van patienten met psoriasisNed Tijdschr Geneeskd1985129114854863990832
   PubMedGoogle Scholar
• DubielWHappleR[Experimental treatment with fumaric acid monoethylester in psoriasis vulgaris] Behandlungsversuch mit Fumarsauremonoathylester bei Psoriasis vulgarisZ Haut Geschlechtskr197247135455504265800
   PubMedGoogle Scholar
• Braun-FalcoO[Letter: Fumaric acid in psoriasis vulgaris] Fumarsaure bei Psoriasis vulgarisDtsch Med Wochenschr19749918977978
   Web of Science ®Google Scholar
• RaabW[Psoriasis therapy with fumaric acid and fumaric acid esters] Psoriasis-Behandlung mit Fumarsaure und FumarsaureesternZ Hautkr198459106716796741206
   PubMedGoogle Scholar
• NieboerCde HoopDvan LoenenACLangendijkPNvan DijkESystemic therapy with fumaric acid derivates: new possibilities in the treatment of psoriasisJ Am Acad Dermatol19892046016082654206
   PubMed Web of Science ®Google Scholar
• BayardWHunzikerTKrebsASpeiserPJoshiR[Peroral long-term treatment of psoriasis using fumaric acid derivatives] Perorale Langzeitbehandlung der Psoriasis mit FumarsaurederivatenHautarzt19873852792853112040
   PubMed Web of Science ®Google Scholar
• KunstLPsoriasis behandelingNed Tijdschr Int Geneesknd19857162429
   Google Scholar
• AltmeyerPJMatthesUPawlakFAntipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patientsJ Am Acad Dermatol19943069779818188891
   PubMed Web of Science ®Google Scholar
• Nugteren-HuyingWMvan der SchroeffJGHermansJSuurmondDFumaric acid therapy for psoriasis: a randomized, double-blind, placebo-controlled studyJ Am Acad Dermatol1990222 pt 13113122312814
   PubMed Web of Science ®Google Scholar
• ReichKThaciDMrowietzUKampsANeureitherMLugerTEfficacy and safety of fumaric acid esters in the long-term treatment of psoriasis – a retrospective study (FUTURE)J Dtsch Dermatol Ges20097760361119459898
   PubMed Web of Science ®Google Scholar
• AugustinMSpehrCRadtkeMAGerman psoriasis registry PsoBest: objectives, methodology and baseline dataJ Dtsch Dermatol Ges2014121485724393314
   PubMed Web of Science ®Google Scholar
• MenterAKormanNJElmetsCAGuidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agentsJ Am Acad Dermatol200961345148519493586
   PubMed Web of Science ®Google Scholar
• AnsteyAVFumaric acid esters in the treatment of psoriasisBr J Dermatol20101622237238
   Web of Science ®Google Scholar
• HeelanKMarkhamTFumaric acid esters as a suitable first-line treatment for severe psoriasis: an Irish experienceClin Exp Dermatol201237779379522548419
   PubMed Web of Science ®Google Scholar
• Fallah AraniSBalakDMNeumannHAKuipersMVThioHBTreatment of psoriasis with non-registered fumaric acid esters in The Netherlands: a nationwide survey among Dutch dermatologistsJ Eur Acad Dermatol Venereol201428797297523822581
   PubMed Web of Science ®Google Scholar
• HaringNMahrHSMundleMStrohalRLhottaKEarly detection of renal damage caused by fumaric acid ester therapy by determination of urinary beta2-microglobulinBr J Dermatol2011164364865121143462
   PubMed Web of Science ®Google Scholar
• CarboniIDe FeliceCDe SimoniISodaRChimentiSFumaric acid esters in the treatment of psoriasis: an Italian experienceJ Dermatolog Treat2004151232614754645
   PubMedGoogle Scholar
• KokeljFPlozzerCAvianATrevisanGFumaric acid and its derivatives in the treatment of psoriasis vulgaris: our experience in forty-one patientsActa Dermatovenerol Croat200917317017519818215
   PubMed Web of Science ®Google Scholar
• PathiranaDOrmerodADSaiagPEuropean S3-guidelines on the systemic treatment of psoriasis vulgarisJ Eur Acad Dermatol Venereol200923suppl 2170
   PubMed Web of Science ®Google Scholar
• ArbiserJLFumarate esters as angiogenesis inhibitors: key to action in psoriasis?J Invest Dermatol201113161189119121566578
   PubMed Web of Science ®Google Scholar
• MeissnerMValeskyEMKippenbergerSKaufmannRDimethyl fumarate – only an anti-psoriatic medication?J Dtsch Dermatol Ges2012101179380122897153
   PubMed Web of Science ®Google Scholar
• BreuerKGutzmerRVolkerBKappAWerfelTTherapy of noninfectious granulomatous skin diseases with fumaric acid estersBr J Dermatol200515261290129515948995
   PubMed Web of Science ®Google Scholar
• KleinACorasBLandthalerMBabilasPOff-label use of fumarate therapy for granulomatous and inflammatory skin diseases other than psoriasis vulgaris: a retrospective studyJ Eur Acad Dermatol Venereol201226111400140622007931
   PubMed Web of Science ®Google Scholar
• GoldRKapposLArnoldDLPlacebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosisN Engl J Med2012367121098110722992073
   PubMed Web of Science ®Google Scholar
• FoxRJMillerDHPhillipsJTCONFIRM Study InvestigatorsPlacebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosisN Engl J Med2012367121087109722992072
   PubMed Web of Science ®Google Scholar
• ZweegersJde JongEMNijstenTESummary of the Dutch S3-guidelines on the treatment of psoriasis 2011Dermatol Online J2014203 ii:doj_21769
   Google Scholar
• NastABoehnckeWHMrowietzUS3 – guidelines on the treatment of psoriasis vulgaris (English version). UpdateJ Dtsch Dermatol Ges2012102S1S95
   Web of Science ®Google Scholar
• NieboerCde HoopDLangendijkPNvan LoenenACGubbelsJFumaric acid therapy in psoriasis: a double-blind comparison between fumaric acid compound therapy and monotherapy with dimethylfumaric acid esterDermatologica1990181133372394301
   PubMedGoogle Scholar
• Fallah AraniSNeumannHHopWCThioHBFumarates vs methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trialBr J Dermatol2011164485586121175564
   PubMed Web of Science ®Google Scholar
• GollnickHAltmeyerPKaufmannRTopical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgarisDermatology20022051465312145434
   PubMed Web of Science ®Google Scholar
• BalakDMFallah-AraniSVenemaCMNeumannHAThioHBAddition of an oral histamine antagonist to reduce adverse events associated with fumaric acid esters in the treatment of psoriasis: a randomized double-blind placebo-controlled trialBr J Dermatol Epub2014717
   Google Scholar
• SchulzKFAltmanDGMoherDGroup CCONSORT 2010 statement: updated guidelines for reporting parallel group randomised trialsBMJ2010340c33220332509
   PubMed Web of Science ®Google Scholar
• WainEMDarlingMIPleassRDBarkerJNSmithCHTreatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective studyBr J Dermatol2010162242743419519838
   PubMed Web of Science ®Google Scholar
• GambichlerTKreuterASusokLGlutathione-S-transferase T1 genotyping and phenotyping in psoriasis patients receiving treatment with oral fumaric acid estersJ Eur Acad Dermatol Venereol201428557458023489263
   PubMed Web of Science ®Google Scholar
• GambichlerTBecharaFGScolaNRotterdamSAltmeyerPSkryganMSerum levels of antimicrobial peptides and proteins do not correlate with psoriasis severity and are increased after treatment with fumaric acid estersArch Dermatol Res2012304647147422410863
   PubMed Web of Science ®Google Scholar
• GambichlerTScolaNRotterdamSMonitoring peripheral blood CD4(+) intracellular adenosine triphosphate concentration in patients with psoriasis treated with fumaric acid estersActa Derm Venereol201292436436622294455
   PubMed Web of Science ®Google Scholar
• BoehnckeSFichtlschererSSalgoRSystemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trialArch Dermatol Res2011303638138821170539
   PubMed Web of Science ®Google Scholar
• LitjensNHNibberingPHBarroisAJBeneficial effects of fumarate therapy in psoriasis vulgaris patients coincide with down-regulation of type 1 cytokinesBr J Dermatol2003148344445112653735
   PubMed Web of Science ®Google Scholar
• FriedrichMSterryWKleinARuckertRDockeWDAsadullahKAddition of pentoxifylline could reduce the side effects of fumaric acid esters in the treatment of psoriasisActa Derm Venereol2001816429430
   Web of Science ®Google Scholar
• HöxtermannSNuchelCAltmeyerPFumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasisDermatology199819622232309568412
   PubMed Web of Science ®Google Scholar
• AltmeyerPHartwigRMatthesU[Efficacy and safety profile of fumaric acid esters in oral long-term therapy with severe treatment refractory psoriasis vulgaris. A study of 83 patients] Das Wirkuns- und Sicherheitsprofil von Fumarsaureestern in der oralen Langzeittherapie bei schwerer therapieresistenter Psoriasis vulgaris. Eine Untersuchung an 83 PatientenHautarzt19964731901968647701
   PubMed Web of Science ®Google Scholar
• KolbachDNNieboerCFumaric acid therapy in psoriasis: results and side effects of 2 years of treatmentJ Am Acad Dermatol1992275 pt 17697711430403
   PubMed Web of Science ®Google Scholar
• WalkerFAdamczykAKellererCFumaderm in daily practice for psoriasis – dosing, efficacy and quality of lifeBr J Dermatol Epub2014510
   Web of Science ®Google Scholar
• MrowietzUChristophersEAltmeyerPTreatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre StudyBr J Dermatol199813834564609580799
   PubMed Web of Science ®Google Scholar
• BalakDMOostveenAMBousemaMTEffectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The NetherlandsBr J Dermatol201316861343134723738641
   PubMed Web of Science ®Google Scholar
• ThaçiDWeisenseelPPhilippSEfficacy and safety of fumaric acid esters in patients with psoriasis on medication for comorbid conditions – a retrospective evaluation (FACTS)J Dtsch Dermatol Ges201311542943523433431
   PubMed Web of Science ®Google Scholar
• IsmailNCollinsPRogersSKirbyBLallyADrug survival of fumaric acid esters for psoriasis: a retrospective studyBr J Dermatol2014171239740224471408
   PubMed Web of Science ®Google Scholar
• InzingerMWegerWHeschlBSalmhoferWQuehenbergerFWolfPMethotrexate vs fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditionsJ Eur Acad Dermatol Venereol201327786186622672248
   PubMed Web of Science ®Google Scholar
• HoefnagelJJThioHBWillemzeRBouwes BavinckJNLong-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasisBr J Dermatol2003149236336912932244
   PubMed Web of Science ®Google Scholar
• ThioHBVan Der SchroeffJGNugteren-HuyingWMVermeerBJLong-term systemic therapy with dimethylfumarate and monoethyl-fumarate (Fumaderm) in psoriasisJ Eur Acad Dermatol Venereol1995413540
   Google Scholar
• BrewerLRogersSFumaric acid esters in the management of severe psoriasisClin Exp Dermatol200732324624917362235
   PubMed Web of Science ®Google Scholar
• SladdenMJOsborneJEHutchinsonPEFumaric acid esters for severe psoriasis: the Leicestershire experienceBr J Dermatol2006155484384416965442
   PubMed Web of Science ®Google Scholar
• FikaZWilliamsREWilliamsonDJFumaric acid esters in psoriasisBr J Dermatol2006154356756816445802
   PubMed Web of Science ®Google Scholar
• HarriesMJChalmersRJGriffithsCEFumaric acid esters for severe psoriasis: a retrospective review of 58 casesBr J Dermatol2005153354955116120141
   PubMed Web of Science ®Google Scholar
• BalasubramaniamPStevensonOBerth-JonesJFumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalitiesBr J Dermatol2004150474174615099371
   PubMed Web of Science ®Google Scholar
• BoehnckeSSalgoRGarbaravicieneJEffective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational studyJ Eur Acad Dermatol Venereol201125101187119321241371
   PubMed Web of Science ®Google Scholar
• van LumigPPDriessenRJKievitWBoezemanJBvan de KerkhofPCde JongEMResults of three analytical approaches on long-term efficacy of etanercept for psoriasis in daily practiceJ Am Acad Dermatol2013681576322846689
   PubMed Web of Science ®Google Scholar
• MrowietzUChristophersEAltmeyerPTreatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus ConferenceBr J Dermatol1999141342442910584060
   PubMed Web of Science ®Google Scholar
• HansonJGilleAOffermannsSRole of HCA(2) (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skinPharmacol Ther201213611722743741
   PubMed Web of Science ®Google Scholar
• HansonJGilleAZwykielSNicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in miceJ Clin Invest201012082910291920664170
   PubMed Web of Science ®Google Scholar
• HessamSAltmeyerPStuckerMDickelHDimethylfumarate in the treatment of psoriasis – a hitherto unnoticed source of sensitization? A case series and review of the literatureAllergologie20133611927
   Web of Science ®Google Scholar
• TornatoreCAmjadFAttenuation of dimethyl fumarate-related gastrointestinal symptoms with montelukastNeurology20148210 Supplement P7.251
   Google Scholar
• AsadullahKSchmidHFriedrichMInfluence of monomethyl-fumarate on monocytic cytokine formation – explanation for adverse and therapeutic effects in psoriasis?Arch Dermatol Res1997289116236309444385
   PubMed Web of Science ®Google Scholar
• OgilvieSLewis JonesSDaweRFoersterJProteinuria with fumaric acid ester treatment for psoriasisClin Exp Dermatol201136663263421771009
   PubMed Web of Science ®Google Scholar
• RoodnatJIChristiaansMHNugteren-HuyingWMvan der SchroeffJGChangPC[Acute kidney insufficiency in patients treated with fumaric acid esters for psoriasis] Acute nierinsufficientie bij patienten behandeld met fumaarzuuresters wegens psoriasisNed Tijdschr Geneeskd198913352262326262608146
   PubMedGoogle Scholar
• BoeskenWHOserBRothJWedekindSWokalekHNephrotoxic effects of fumaric acid therapy of psoriasisNieren- und Hochdruckkrankheiten1998273145150
   Google Scholar
• FliegnerLSpiegelP[Osteomalacia as an apparently rare side effect of oral fumaric acid therapy. Secondary DeToni-Debre Fanconi syndrome in the adult] Osteomalazie als offenbar seltene Nebenwirkung der oralen Fumarsauretherapie. Sekundares DeToni-Debre Fanconi-Syndrom des ErwachsenenHautarzt19924395545601399600
   PubMed Web of Science ®Google Scholar
• SchillingSGoelzSLinkerRLuehderFGoldRFumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltrationClin Exp Immunol2006145110110716792679
   PubMed Web of Science ®Google Scholar
• RaschkaCKochHJLongterm treatment of psoriasis using fumaric acid preparations can be associated with severe proximal tubular damageHum Exp Toxicol1999181273873910627662
   PubMed Web of Science ®Google Scholar
• WarzechaJRunckAPriepkeEStormHWeigandHMultiple pathological fractures in acquired Fanconi’s syndrome after treatment of psoriasis with fumaric acidUnfallchirurg2001104544845111413962
   PubMed Web of Science ®Google Scholar
• HavivYSZimmermanMBerkmanNSafadiRFumaric acid ester-induced diffuse renal tubular injury presenting as Fanconi syndrome and osteomalaciaClin Drug Investig1999174333335
   Web of Science ®Google Scholar
• ReidCHolianJKaneDKirbyBDe Toni-Fanconi syndrome secondary to fumaric acid estersBr J Dermatol2013169 (Reid C.; Kirby B.) Department of Dermatology, St Vincent’s University Hospital, Dublin, Ireland24
   Web of Science ®Google Scholar
• DeeganAPKirbyBRogersSCrottyTBMcDonnellTJOrganising pneumonia associated with fumaric acid ester treatment for psoriasisClin Respir J20104424825120887349
   PubMed Web of Science ®Google Scholar
• JenningsLMurphyGSquamous cell carcinoma as a complication of fumaric acid ester immunosuppressionJ Eur Acad Dermatol Venereol200923121451
   Web of Science ®Google Scholar
• BarthDSimonJCWetzigTMalignant melanoma during treatment with fumaric acid esters – coincidence or treatment-related?J Dtsch Dermatol Ges20119322322520678147
   PubMed Web of Science ®Google Scholar
• PhilippSKokolakisGHundMImmunological changes in psoriasis patients under long-term treatment with fumaric acid esters: risk of Kaposi sarcoma occurrence?Eur J Dermatol201323333934323774790
   PubMed Web of Science ®Google Scholar
• ErmisUWeisJSchulzJBPML in a patient treated with fumaric acidN Engl J Med2013368171657165823614603
   PubMed Web of Science ®Google Scholar
• van OostenBWKillesteinJBarkhofFPolmanCHWattjesMPPML in a patient treated with dimethyl fumarate from a compounding pharmacyN Engl J Med2013368171658165923614604
   PubMed Web of Science ®Google Scholar
• PhillipsJTHutchinsonMFoxRGoldRHavrdovaEManaging flushing and gastrointestinal events associated with delayed-release dimethyl fumarate: experiences of an international panelMult Scler Relat Disord20143451351925877064
   PubMed Web of Science ®Google Scholar
• SheikhSINestorovIRussellHTolerability and pharmacokinetics of delayed-release dimethyl fumarate administered with and without aspirin in healthy volunteersClin Ther201335101582.e91594.e924139424
   PubMed Web of Science ®Google Scholar
• WerdenbergDJoshiRWolfframSMerkleHPLangguthPPresystemic metabolism and intestinal absorption of antipsoriatic fumaric acid estersBiopharm Drug Dispos200324625927312973823
   PubMed Web of Science ®Google Scholar
• LitjensNHvan StrijenEvan GulpenCIn vitro pharmacokinetics of anti-psoriatic fumaric acid estersBMC Pharmacol200442215479475
   PubMedGoogle Scholar
• LitjensNHBurggraafJvan StrijenEPharmacokinetics of oral fumarates in healthy subjectsBr J Clin Pharmacol200458442943215373936
   PubMed Web of Science ®Google Scholar
• Rostami-YazdiMClementBMrowietzUPharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patientsArch Dermatol Res2010302753153820574745
   PubMed Web of Science ®Google Scholar
• SchmidtTJAkMMrowietzUReactivity of dimethyl fumarate and methylhydrogen fumarate towards glutathione and N-acetyl-L-cysteine – preparation of S-substituted thiosuccinic acid estersBioorg Med Chem200715133334217049250
   PubMed Web of Science ®Google Scholar
• DibbertSClementBSkak-NielsenTMrowietzURostami-YazdiMDetection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolismArch Dermatol Res2013305544745123525570
   PubMed Web of Science ®Google Scholar
• Rostami-YazdiMClementBSchmidtTJSchinorDMrowietzUDetection of metabolites of fumaric acid esters in human urine: implications for their mode of actionJ Invest Dermatol2009129123123418704112
   PubMed Web of Science ®Google Scholar
• LehmannJCListopadJJRentzschCUDimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1J Invest Dermatol2007127483584517235328
   PubMed Web of Science ®Google Scholar
• GhoreschiKBrückJKellererCFumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cellsJ Exp Med2011208112291230321987655
   PubMed Web of Science ®Google Scholar
• StoofTJFlierJSampatSNieboerCTensenCPBoorsmaDMThe antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cellsBr J Dermatol200114461114112011422029
   PubMed Web of Science ®Google Scholar
• ZhuKMrowietzUInhibition of dendritic cell differentiation by fumaric acid estersJ Invest Dermatol2001116220320811179994
   PubMed Web of Science ®Google Scholar
• PengHGuerau-de-ArellanoMMehtaVBDimethyl fumarate inhibits dendritic cell maturation via nuclear factor kappaB (NF-kappaB) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and mitogen stress-activated kinase 1 (MSK1) signalingJ Biol Chem201228733280172802622733812
   PubMed Web of Science ®Google Scholar
• TreumerFZhuKGlaserRMrowietzUDimethylfumarate is a potent inducer of apoptosis in human T cellsJ Invest Dermatol200312161383138814675187
   PubMed Web of Science ®Google Scholar
• OckenfelsHMSchultewolterTOckenfelsGFunkRGoosMThe antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine networkBr J Dermatol199813933903959767281
   PubMed Web of Science ®Google Scholar
• OnderdijkAJBalakDMBaerveldtEMRegulated genes in psoriasis skin during treatment with fumaric acid estersBr J Dermatol2014171473274124852654
   PubMed Web of Science ®Google Scholar
• WallbrechtKDrickNHundACSchonMPDownregulation of endothelial adhesion molecules by dimethylfumarate, but not monomethylfumarate, and impairment of dynamic lymphocyte-endothelial cell interactionsExp Dermatol2011201298098521995308
   PubMed Web of Science ®Google Scholar
• RubantSALudwigRJDiehlSDimethylfumarate reduces leukocyte rolling in vivo through modulation of adhesion molecule expressionJ Invest Dermatol2008128232633117671516
   PubMed Web of Science ®Google Scholar
• SebokBBonnekohBGeiselJMahrleGAntiproliferative and cytotoxic profiles of antipsoriatic fumaric acid derivatives in keratinocyte culturesEur J Pharmacol1994270179878157084
   PubMed Web of Science ®Google Scholar
• BovenschenHJLangewoutersAMvan de KerkhofPCDimethylfumarate for psoriasis: pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical studyAm J Clin Dermatol201011534335020553063
   PubMed Web of Science ®Google Scholar
• GesserBRasmussenMKRaabyLDimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expressionInflamm Res201160764365321340650
   PubMed Web of Science ®Google Scholar
• ThioHBZomerdijkTPOudshoornCFumaric acid derivatives evoke a transient increase in intracellular free calcium concentration and inhibit the proliferation of human keratinocytesBr J Dermatol199413168568617857839
   PubMed Web of Science ®Google Scholar
• MeissnerMDollMHrgovicISuppression of VEGFR2 expression in human endothelial cells by dimethylfumarate treatment: evidence for anti-angiogenic actionJ Invest Dermatol201113161356136421430706
   PubMed Web of Science ®Google Scholar
• BG 12: BG 00012, BG 12/Oral Fumarate, FAG-201, second-generation fumarate derivative – Fumapharm/Biogen IdecDrugs R D20056422923015991882
   PubMedGoogle Scholar
• MrowietzUReichKSpellmanMCTreatment of moderate-to-severe psoriasis with oral dimethyl fumarate (BG00012): results of a multicentre, randomized, double-blind, placebo-controlled trialBr J Dermatol20061547816403088
   PubMed Web of Science ®Google Scholar
• WakkeeMThioHBDrug evaluation: BG-12, an immunomodulatory dimethylfumarateCurr Opin Investig Drugs2007811955962
   PubMedGoogle Scholar
• SkariaASchmidUTopische behandlung mit fumarsalbe 3%: eine klinisch-histopathologische studieZ Hautkr199368321322
   Google Scholar
• de HaanPvon Blomberg-van der FlierBMde GrootJNieboerCBruynzeelDPThe risk of sensibilization and contact urticaria upon topical application of fumaric acid derivativesDermatology199418821261308136539
   PubMed Web of Science ®Google Scholar
• DuckerPPfeiffB[Two cases of side effects of a fumaric acid ester – local therapy] Zwei Falle von Nebenwirkungen einer Fumarsaureester – LokaltherapieZ Hautkr19906587347362149475
   PubMedGoogle Scholar
• DoumitJGaviganGPrattMAllergic contact dermatitis from dimethyl fumarate after contact with a Chinese sofaJ Cutan Med Surg201216535335622971312
   PubMed Web of Science ®Google Scholar
• D’ErmeAMBassiALottiTGolaMDimethyl fumarate contact dermatitis of the foot: an increasingly widespread diseaseInt J Dermatol2012511424521913908
   PubMed Web of Science ®Google Scholar
• SchmidUHTopical application of fumaric acid derivativesDermatology19951903253
   Web of Science ®Google Scholar
• SkariaAMSchmidUAntipsoriatic effect of fumaric acid derivatesJ Am Acad Dermatol1996342 pt 13233248642109
   PubMed Web of Science ®Google Scholar
• Van LumigPPDriessenRJBoezemanJBVan De KerkhofPCDe JongEMLong-term efficacy of etanercept for psoriasis in daily practiceBr J Dermatol2012166244544721910699
   PubMed Web of Science ®Google Scholar
• RaczEDolhainRJEMThioHBPrensEPPsoriasis patients who are less responsive to biologic treatments: switch or combine?Nederlands Tijdschrift voor Dermatologie en Venereologie2012222117119
   Google Scholar
• ReichKBraeuBMertenKGriembergWEfficacy, safety and dosage of fumaric acid esters in combination with phototherapy in patients with moderate to severe plaque-type psoriasisJ Eur Acad Dermatol Venereol201327 (Reich K.) Dermatologikum Hamburg, Hamburg, Germany1415
   Web of Science ®Google Scholar
• WollinaULangnerDTreatment of disseminated granuloma annulare recalcitrant to topical therapy: a retrospective 10-year analysis with comparison of photochemotherapy alone versus photochemotherapy plus oral fumaric acid estersJ Eur Acad Dermatol Venereol201226101319132122035266
   PubMed Web of Science ®Google Scholar
• GerdesSDommSMrowietzULong-term treatment with fumaric acid esters in an 11-year-old male child with psoriasisDermatology2011222319820021502753
   PubMed Web of Science ®Google Scholar
• GuntherCHSchmittJWozelGSuccessive use of fumaric acid esters for the treatment of psoriasis vulgaris in a 14-year-old patientHaut20041512830
   Google Scholar
• StanderHStadelmannALugerTTraupeHEfficacy of fumaric acid ester monotherapy in psoriasis pustulosa palmoplantarisBr J Dermatol2003149122022212890235
   PubMed Web of Science ®Google Scholar
• PawlakFMMatthesUBacharach-BuhlesMAltmeyerPTreatment of refractory psoriasis pustulosa generalisata with fumaric acid estersAktuelle Derm1993191–268
   Google Scholar
• PeetersAJDijkmansBAvan der SchroeffJGFumaric acid therapy for psoriatic arthritis. A randomized, double-blind, placebo-controlled studyBr J Rheumatol19923175025041628175
   PubMedGoogle Scholar
• VlachouCBerth-JonesJNail psoriasis improvement in a patient treated with fumaric acid estersJ Dermatolog Treat200718317517717538807
   PubMed Web of Science ®Google Scholar
• MrowietzUReichKCase reports of PML in patients treated for psoriasisN Engl J Med2013369111080108124024861
   PubMed Web of Science ®Google Scholar
• FellnerADanoMRegevKMosekAKarniAMultiple sclerosis is associated with psoriasis. A case-control studyJ Neurol Sci20143381–222622824439200
   PubMed Web of Science ®Google Scholar
• GkalpakiotisSArenbergerPGkalpakiotiPMeluzinovaEChandranDArenbergerovaMManagement of psoriasis vulgaris and multiple sclerosis with fumaric acidJ Am Acad Dermatol2014703e60e6124528918
   PubMed Web of Science ®Google Scholar
• ZeccaCCaporroMAdamiMMainettiCGobbiCFumaric acid esters in psoriasis and multiple sclerosisClin Exp Dermatol201439448849124779791
   PubMed Web of Science ®Google Scholar
• TsianakasAHerzogSLandmannASuccessful treatment of discoid lupus erythematosus with fumaric acid estersJ Am Acad Dermatol2014711e15e1724947703
   PubMed Web of Science ®Google Scholar
• WinchesterDDuffinKCHansenCResponse to ustekinumab in a patient with both severe psoriasis and hypertrophic cutaneous lupusLupus20122191007101022438028
   PubMed Web of Science ®Google Scholar
• AshrafianHCzibikGBellahceneMFumarate is cardioprotective via activation of the Nrf2 antioxidant pathwayCell Metab201215336137122405071
   PubMed Web of Science ®Google Scholar
• ŠilhavýJZídekVMlejnekPFumaric acid esters can block pro-inflammatory actions of human CRP and ameliorate metabolic disturbances in transgenic spontaneously hypertensive ratsPLoS ONE [Electronic Resource]201497e101906
   Web of Science ®Google Scholar
• GillAJKolsonDLDimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapyCrit Rev Immunol201333430735923971529
   PubMed Web of Science ®Google Scholar
• CrossSACookDRChiAWDimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotectionJ Immunol2011187105015502521976775
   PubMed Web of Science ®Google Scholar
• SchmittJZhangZWozelGMeurerMKirchWEfficacy and toler-ability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trialsBr J Dermatol2008159351352618627372
   PubMed Web of Science ®Google Scholar
• SchmittJRosumeckSThomaschewskiGSporbeckBHaufeENastAEfficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trialsBr J Dermatol2014170227430324131260
   PubMed Web of Science ®Google Scholar
• RappSRFeldmanSRExumMLFleischerABJrReboussinDMPsoriasis causes as much disability as other major medical diseasesJ Am Acad Dermatol1999413 pt 140140710459113
   PubMed Web of Science ®Google Scholar
• NaldiLGriffithsCETraditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risksBr J Dermatol2005152459761515840088
   PubMed Web of Science ®Google Scholar
• van de KerkhofPCTherapeutic strategies: rotational therapy and combinationsClin Exp Dermatol200126435636111422189
   PubMed Web of Science ®Google Scholar
• SiztoSBansbackNFeldmanSRWillianMKAnisAHEconomic evaluation of systemic therapies for moderate to severe psoriasisBr J Dermatol200916061264127219120346
   PubMed Web of Science ®Google Scholar
• van de KerkhofPBarkerJGriffithsCEInternational Psoriasis CouncilImproving clinical trial design in psoriasis: perspectives from the global dermatology communityJ Dermatolog Treat201122418719320887207
   PubMed Web of Science ®Google Scholar
• BarkerJNMethotrexate or fumarates: which is the best oral treatment for psoriasis?Br J Dermatol2011164469521457199
   PubMed Web of Science ®Google Scholar